Anna Sussman | Senior Director, Investor Relations |
Patrick Mahaffy | President and Chief Executive Officer |
Dan Muehl | Senior Vice President of Finance and Principal Financial and Accounting Officer |
Lindsey Rolfe | Executive Vice President of Clinical and Preclinical Development and Pharmacovigilance and Chief Medical Officer |
Tazeen Ahmad | Bank of America |
Gena Wang | Barclays Capital |
Kennen MacKay | RBC Capital Markets |
Cory Kasimov | JPMorgan |
Asthika Goonewardene | Bloomberg Intelligence |
Yige Guo | Guggenheim Partners |
Good morning. My name is Mariama and I will be your conference operator today. At this time, I would like to welcome everyone to the Clovis Oncology Q4, Year-End 2018 Financial Results Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.